S1 Text -

<p><b>Table A.</b> Study sites. <b>Table B.</b> Clinical variables included in the logistic regression analysis used to create the risk score. <b>Table C.</b> Enrollment and demographic data at each study site. <b>Table D.</b> Presence of individual components of the AKD risk score in all patients and at each site. <b>Table E.</b> Multivariable analysis of factors associated with the development of AKD. <b>Table F.</b> Type of infection and main site of infection in patients with AKD in whom infection was a contributor to AKD development. <b>Table G.</b> Multivariable analysis of factors associated with mortality. <b>Table H.</b> Patient and kidney outcomes at healthcare facility discharge and at 90-day follow-up in patients with AKD with AKI. <b>Table I.</b> Prevalence, causes of kidney disease, and clinical outcomes in this and other studies within the 0by25 initiative. <b>Fig A.</b> Histograms of enrollment creatinine and eGFR in the entire cohort.</p> <p>(DOCX)</p>